Klinik und Therapie der Clostridium difficile-Erkrankung

  • K. Loeschke
Conference paper

Zusammenfassung

Im Gegensatz zur Pathophysiologie ist die klinische Symptomatik der Erkrankung durch Clostridium difficile seit mindestens 15 Jahren gut bekannt, das therapeutische Vorgehen steht seither im Wesentlichen fest [Übersichten u.a. 2, 4, 6, 18, 36]. Dennoch scheint die Erkrankung im Bewußtsein der Ärzte noch nicht sicher verankert zu sein. Neben einer etwas unübersichtlichen Nomenklatur mag das an einem trotz aller Fortbildungsbemühungen mangelhaften Bekanntheitsgrad liegen. Insofern lohnt sich eine kurze Wiederholung der wichtigsten Tatsachen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Anand A, Bashey B, Mir T, Glatt AE (1994) Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea. Am J Gastroenterol 89: 519–523PubMedGoogle Scholar
  2. 2.
    Bartlett JG (1994) Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 18, S 265–272CrossRefGoogle Scholar
  3. 3.
    Cartmill TDI, Panigrahi H, Worsley MA, McCann DC, Nice CN, Keith E (1994) Management and control of a large outbreak of diarrhoea due to Clostridium difficile. J Hosp Infect 27: 1–15PubMedCrossRefGoogle Scholar
  4. 4.
    Fekety R (1995) Antibiotic-associated diarrhea and colitis. Current Opinion Infect Dis 8: 391–397CrossRefGoogle Scholar
  5. 5.
    Fekety R, Silva J, Kauffman C, Buggy B, Gunner H (1989) Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 86: 15–19PubMedCrossRefGoogle Scholar
  6. 6.
    Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J,jr (1995) Clostridium difficile- associated diarrhea and colitis. Infect Control Hosp Epidemiol 16: 459–477Google Scholar
  7. 7.
    Gryboski JD, Pellerano R, Young N, Edberg S (1991) Positive role of Clostridium difficile infection in diarrhea in infants and children. Am J Gastroenterol 86: 685–689PubMedGoogle Scholar
  8. 8.
    Heerze LD, Keim MA, Talbot JA, Armstrong GD (1994) Oligosaccharide sequences atta-ched to an inert support (SYNSORB) as potential therapy for antibiotic-associated diarrhea and pseudomembranous colitis. J Infect Dis 169: 1291–1296Google Scholar
  9. 9.
    Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC (1995) Clostridium difficile colitis: An increasing hospital-acquired illness. Am J Surg 169: 480–483Google Scholar
  10. 10.
    Johnson S, Homann SR, Bettin KM, Quick JN, Clabots CR, Peterson LR, Gerding DN (1992) Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Int Med 117: 297–302Google Scholar
  11. 11.
    Keighley MRB, Burdon DW, Arabi Y, Alexander-Williams J, Thompson H, Youngs D, Johnson M, Bentley S, George RH, Mogg GAG (1978) Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhea. B Med J 2: 1667–1669CrossRefGoogle Scholar
  12. 12.
    Krammer M, Karbach U (1993) Antidiarrheal action of the yeast Saccharomyces boulardii in the rat small and large intestine by stimulating chloride absorption. Z Gastroenterol 31: 73–77Google Scholar
  13. 13.
    Kreisel D, Savel TG, Silver AL, Cunningham JD (1995) Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 130: 989–993PubMedCrossRefGoogle Scholar
  14. 14.
    Loeschke K (1980) Antibiotika-assoziierte Diarrhoe und Enterokolitis. Klin Wschr 58: 337–345PubMedCrossRefGoogle Scholar
  15. 15.
    Loeschke K, Hauck R, Halbritter R, Pfaller P, Ruckdeschel G (1983) Clostridium difficile und Antibiotika-assoziierte Kolitis bei Risikopatienten: Zweimonatige epidemiologische Studie auf einer Intensiveinheit. Klin Wschr 61: 1081–1087Google Scholar
  16. 16.
    Loeschke K, Kautz U, Lohrs U (1980) Effects of antibiotics on caecal electrolyte transport and morphology in rats. Contribution to the pathogenesis of antibiotic-associated diarrhoea. Klin Wschr 58: 383–385Google Scholar
  17. 17.
    Loeschke K, Ruckdeschel G (1989) Antibiotikaassoziierte Kolitis - aktualisiert. Internist 30: 345–351PubMedGoogle Scholar
  18. 18.
    Loeschke K, Ruckdeschel G (1992) Durchfälle unter Antibiotika. Dtsch Ärztebl 89: B-221–224Google Scholar
  19. 19.
    Loeschke K, Tredup J, Ruckdeschel G (1984) Klinik der Antibiotika-assoziierten Kolitis. Fortschr Antimikr Antineopl Chemother (FAC) 3-3: 409–418Google Scholar
  20. 20.
    McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL (1995) Prevention of ß-Lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 90: 439–448PubMedGoogle Scholar
  21. 21.
    McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL, Noorani Z, Harrington G, Rubin M, Greenwald D (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271: 1913–1918PubMedCrossRefGoogle Scholar
  22. 22.
    Nath SK, Thornley JH, Kelly M, Kucera B, On SLW, Holmes B, Costas M (1994) A sustained outbreak of Clostridium difficile in a general hospital: Persistence of a toxigenic clone in four units. Infect Control Hosp Epidemiol 15: 382–389Google Scholar
  23. 23.
    Nelson DE, Auerbach SB, Baltch AL, Desjardin E, Beck-Sague C, Rheal C, Smith RP, Jarvis WR (1994) Epidemic Clostridium difficile-associated diarrhea: Role of second- and third- generation cephalosporins. Infect Control Hosp Epidemiol 15: 88–94Google Scholar
  24. 24.
    Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN (1994) Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Int Med 120: 272–277PubMedGoogle Scholar
  25. 25.
    Pothoulakis C, Kelly CP, Joshi MA, Gao N, O’Keane CJ, Castagliuolo I, Lamont T (1993) Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 104: 1108–1115PubMedGoogle Scholar
  26. 26.
    Prendergast TM, Marini CP, D’Angelo AJ,Sher ME, Cohen JR (1994) Surgical patients with pseudomembranous colitis: Factors affecting prognosis. Surgery 116: 768–775Google Scholar
  27. 27.
    Rubin MS, Bodenstein LE, Kent KC (1995) Severe Clostridium difficile colitis. Dis Colon Rectum 38: 350–354PubMedCrossRefGoogle Scholar
  28. 28.
    Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW (1994) Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 18: 181–187PubMedCrossRefGoogle Scholar
  29. 29.
    Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G (1989) Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study. Gastroenterology 96: 981–988Google Scholar
  30. 30.
    Surawicz CM, McFarland LV, Elmer G, Chinn J (1989) Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 84: 1285–287PubMedGoogle Scholar
  31. 31.
    Tedesco FJ, Gordon D, Fortson WC (1985) Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 80: 867–868PubMedGoogle Scholar
  32. 32.
    The Swedish CD AD Study Group (1994) Treatment of Clostridium difficile associated diarrhea and colitis with an oral preparation of teicoplanin; a dose finding study. Scand J Infect Dis 26: 309–316CrossRefGoogle Scholar
  33. 33.
    Tredup J (1985) Clostridium difficile im Stuhl: Klinische Bedeutung bei 110 Patienten aus Krankenhäusern in München. Med. Dissertation LMU MünchenGoogle Scholar
  34. 34.
    Triadafilopoulos G, Hallstone AE (1991) Acute abdomen as the first presentation of pseudomembranous colitis. Gastroenterology 101: 685–691PubMedGoogle Scholar
  35. 35.
    Tumbarello M, Tacconelli E, Leone F, Cauda R, Ortona L (1995) Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study. Eur J Gastroenterol Hepatol 7: 259–263PubMedGoogle Scholar
  36. 36.
    Wehrmann T, Lembcke B (1995) Antibiotika-assoziierte Durchfälle. Z Gastroenterol 33 (Suppl 2): 35–40Google Scholar
  37. 37.
    Wilcox MH, Howe R (1995) Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. J Antimicr Chemother 36: 673–679CrossRefGoogle Scholar
  38. 38.
    Yee J, Dixon CM, McLean APH, Meakins JL (1991) Clostridium difficile disease in a department of surgery. The significance of prophylactic antibiotics. Arch Surg 126: 241–246Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • K. Loeschke

There are no affiliations available

Personalised recommendations